Pralidoxime API Manufacturers

compare suppliers & get competitive offers



Selected filters:

Production region




To view suppliers for this material, you need to be logged in first.






This is because of international laws regarding narcotic materials. Furthermore, the contents of this page are only accessible if you are professionaly active in the pharmaceutical industry. In case you are, it is possible to register on our platform, and after your account is approved by our team you will be able to view suppliers and send your request.



Looking for Pralidoxime API 6735-59-7?

Here you will find a list of producers, manufacturers and traders of Pralidoxime. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Pralidoxim , Pralidoxima , Pralidoxime , Pralidoximum  
Cas Number:
DrugBank number:
Unique Ingredient Identifier:

About Pralidoxime

Why are professionals looking for Pralidoxime? Pralidoxime is an antidote to organophosphate pesticides and chemicals. Organophosphates bind to the esteratic site of acetylcholinesterase, which results initially in reversible inactivation of the enzyme. If given within 24 hours,after organophosphate exposure, pralidoxime reactivates the enzyme cholinesterase by cleaving the phosphate-ester bond formed between the organophosphate and acetylcholinesterase.

You can ask the supplier about all relevant certificates for the product such as CoA, Safety Data Sheet and DMF.

Pralidoxime is a type of Antidotes

Antidotes are a vital subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that play a crucial role in counteracting the toxic effects of certain substances or drugs. These specialized substances are developed to treat and reverse the harmful effects caused by accidental or intentional poisonings, drug overdoses, or adverse reactions.

Antidotes work through various mechanisms to neutralize or counteract the toxic effects of specific substances. They may function by binding to the toxin directly, preventing it from interacting with its target receptors or enzymes. Alternatively, they may stimulate enzymatic pathways that metabolize and eliminate the toxic substance from the body more rapidly.

The development of antidotes involves rigorous research and testing to ensure their safety and efficacy. Clinical trials are conducted to evaluate their effectiveness in treating poisoning cases and to establish appropriate dosing regimens. Furthermore, antidotes are subject to stringent regulatory guidelines to ensure their quality, purity, and consistency.

Medical professionals, particularly toxicologists and emergency healthcare providers, rely on antidotes to manage and treat poisoning emergencies effectively. Antidotes are essential tools in the emergency department and poison control centers, where timely administration can be life-saving.

In summary, antidotes are specialized pharmaceutical APIs designed to counteract the toxic effects of specific substances. Their development, testing, and regulatory compliance are crucial to ensure their efficacy and safety. These critical medications are indispensable in the field of emergency medicine and play a pivotal role in saving lives affected by poisoning incidents.

Pralidoxime (Antidotes), classified under Antidotes, Deterrents, and Toxicologic Agents

Antidotes, Deterrents, and Toxicologic Agents are an important category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that play a critical role in healthcare and toxicology. These substances are designed to counteract the effects of poisons, toxins, and overdoses, thereby saving lives and preventing severe health consequences.

Antidotes are substances that neutralize the toxic effects of certain drugs, chemicals, or poisons. They work by either directly binding to the toxic substance or by blocking its harmful actions on the body. Antidotes are administered in emergency situations to quickly reverse the effects of poisoning and restore normal physiological functions.

Deterrents, on the other hand, are pharmaceutical agents used to discourage or prevent harmful behaviors, such as substance abuse. They are designed to make the ingestion or misuse of certain substances unpleasant or less desirable. Deterrents can be formulated to cause unpleasant side effects, such as nausea or vomiting, when a particular substance is consumed in excessive amounts.

Toxicologic agents encompass a broad range of pharmaceutical APIs used in toxicology studies and research. These substances are employed to investigate the toxicity, metabolism, and mechanisms of action of various chemicals and compounds. Toxicologic agents are vital for understanding the potential hazards and risks associated with certain substances, ensuring the safety of drugs, and developing effective treatments for poisoning cases.

In conclusion, Antidotes, Deterrents, and Toxicologic Agents are essential categories of pharmaceutical APIs that address poisoning emergencies, deter harmful behaviors, and enable toxicological research. Their development and availability are crucial for safeguarding public health, enhancing patient care, and advancing our understanding of toxicology.